Grignaschi G, Sironi F, Samanin R
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Brain Res. 1996 Feb 5;708(1-2):173-6. doi: 10.1016/0006-8993(95)01373-3.
The effect of 5-HT1 and 5-HT2 receptor agonists administered into the paraventricular hypothalamus was studied on the hyperphagia caused by neuropeptide Y (NPY) injected into the same area. The 5-HT2A/2C receptor agonist DOI (10-20 nmol/0.5 microliter) significantly reduced NPY overeating while the 5-HT1A/1B receptor agonist RU 24969 (3.5-14 nmol/0.5 microliter) and the 5-HT1B/2C receptor agonist mCPP (5-20 nmol/0.5 microliter) had no such effect. The 5-HT2A receptor antagonist spiperone (5 microgram/0.5 microliter) and the corticotropin releasing factor antagonist alpha-helical-CRF9-41 (0.5-1 micrograms/0.5 microliter) completely antagonized the effect of 10 nmol DOI.
研究了将5-羟色胺1(5-HT1)和5-羟色胺2(5-HT2)受体激动剂注入下丘脑室旁核,对向同一区域注射神经肽Y(NPY)所引起的摄食过量的影响。5-HT2A/2C受体激动剂DOI(10 - 20纳摩尔/0.5微升)显著降低了NPY引起的暴饮暴食,而5-HT1A/1B受体激动剂RU 24969(3.5 - 14纳摩尔/0.5微升)和5-HT1B/2C受体激动剂mCPP(5 - 20纳摩尔/0.5微升)则没有这种作用。5-HT2A受体拮抗剂螺哌隆(5微克/0.5微升)和促肾上腺皮质激素释放因子拮抗剂α-螺旋-CRF9 - 41(0.5 - 1微克/0.5微升)完全拮抗了10纳摩尔DOI的作用。